Skip to Main Content

Paper Details

Metformin treatment rescues CD8<sup>+</sup> T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD.
J Hepatol
53
2022
CD8, CD8 T cells, CD8 T-cell, CD8+, CD8+ T, CD8+ T-cell, HCC, Metformin, NAFLD, NASH, Non-alcoholic steatohepatitis, PD-1, T cells, advanced HCC, advanced hepatocellular carcinoma, anti-PD-1, hepatic CD8, hepatic CD8 T cells, hepatic CD8 T-cell, hepatocellular carcinoma, immune effector cell, intratumoural CD8 T cells, liver cancer, liver cancers, liver tumours, metformin, mice, murine, non-alcoholic steatohepatitis, patients
Author NameAffiliation
Bernd HeinrichCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Xin Wei WangCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Xin Wei WangCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Tim F GretenCenter for Cancer Research, National Cancer Institute, National Institutes of Health
  • 1 - 4

Datasets

Release 1.2